Navigation Links
FDA Approves New Drug to Fight Advanced Prostate Cancer
Date:5/15/2013

WEDNESDAY, May 15 (HealthDay News) -- The U.S. Food and Drug Administration announced Wednesday that it has approved a drug to help men with advanced prostate cancer whose disease has spread to the bones.

The drug, Xofigo, is targeted to patients with late-stage, metastatic disease that has spread to the bones but not to other organs, the FDA said in a news release. It is meant for patients who have already undergone surgery and/or drug therapies such as hormone-based treatments.

The FDA said Xofigo, marketed by Wayne, N.J.-based Bayer Pharmaceuticals, was approved more than three months ahead of the original August 2013 deadline the agency had set for a complete review. Instead, the drug was reviewed under the agency's "priority" review program, designated for medicines that appear safe and effective in a context where no good alternative therapy exists.

"Xofigo binds with minerals in the bone to deliver radiation directly to bone tumors, limiting the damage to the surrounding normal tissues," Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research, explained in the news release.

In a clinical trial involving more than 800 men with symptomatic prostate cancer that was resistant to hormonal therapy and had spread to the bones, men on Xofigo survived a median of 14 months compared to a little over 11 months for men taking a placebo. Side effects from Xofigo included nausea, diarrhea, vomiting and swelling of the legs and feet. Low levels of red and white blood cells, as well as platelets, were also reported among some patients taking Xofigo, the FDA said.

Pazdur noted that "Xofigo is the second prostate cancer drug approved by the FDA in the past year that demonstrates an ability to extend the survival of men with metastatic prostate cancer." The other drug, Xtandi, was approved by the FDA last August for men with hormone treatmen
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. FDA Approves Morning-After Pill Without a Prescription
2. FDA Approves New “Gummy Bear” Breast Implants, But Albany Plastic Surgeon Urges Caution
3. FDA Approves 1st in New Class of Type 2 Diabetes Drugs
4. FDA Approves New Multiple Sclerosis Drug
5. FDA Approves Drug for Older Women Experiencing Painful Sex
6. FDA Approves Bionic Eye to Help Against Rare Vision Disorder
7. MSSD Approves of the Encinitas School District’s Holistic Education
8. FDA Approves 3 New Drugs for Type 2 Diabetes
9. FDA Approves 1st Skin Patch to Combat Migraines
10. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
11. FDA Approves New Type of Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves New Drug to Fight Advanced Prostate Cancer
(Date:3/6/2015)... Ticket Down is a reputable source for ... has extended their customer appreciation discount code ED-SHEERAN-2015 for added ... England and he began his career in the music industry ... of years Ed Sheeran has become a household name. ... stage he is having the time of his life and ...
(Date:3/6/2015)... March 06, 2015 US Sports Football ... Maryland camps – two non-contact specialty camps and one ... by Perfect Performance Training, located at Bowie State University ... developing position specific skills, speed and strength of football ... Salisbury University with Marvin Graves, former quarterback in the ...
(Date:3/6/2015)... As the Association of American Medical Colleges' ... by 2025 is updated this week and debated in ... preparing by analyzing demographics and pursuing viable solutions for ... factors including the increasing number of retiring doctors, increasing ... Care Act and an uneven distribution of new doctors ...
(Date:3/6/2015)... March 06, 2015 First Choice Emergency ... The new facility is located at 13351 W. Bowles Avenue, ... clinical team is ready 24-7 to provide the highest quality ... Facility Medical Director of First Choice Emergency Room Littleton. ... with the South Metro Denver Chamber of Commerce and a ...
(Date:3/6/2015)... 2015 Magellan Rx Management’s 2014 Medical ... for key trends and statistics on one of the ... from Magellan Rx Management will discuss key findings from ... Hidden Specialty Drug Spend,” a complimentary March 19 webinar, ... Specialty drug spend makes up more than a quarter ...
Breaking Medicine News(10 mins):Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... -- Bioengineers at Rice University have discovered that intense ... than a half-mile beneath the ocean,s surface -- stimulates ... of the properties of natural cartilage. The new method, ... for thousands of arthritis sufferers. , "This tissue-engineering method ...
... breaks down when obesity sets in, study finds , , ... signaling pathway in fat cells that suppresses harmful inflammation ... researchers. The pathway prevents the fat cells -- called ... fatty acids in the diet. , However, the ...
... Nation,s Best-Reimbursed, HARRISBURG, Pa., June 3 ... claims by Pennsylvania nursing,home advocates by saying nursing ... reimbursement rates in the nation., "Year after ... Pennsylvania,nursing homes have received a higher level of ...
... Intelligence and Competitive Analysis, from Thomson Reuters to Analyze Promising ... Research and the U.S. Generics ... ... Thomson Reuters, the,world,s leading source of intelligent information for businesses ...
... and longer waits, NASHVILLE, Tenn., June ... out against drastic payment cuts that could,force ... creating long,waits and dramatically increasing out-of-pocket costs ... changes from The Centers for Medicare and ...
... PITTSBURGH, June 3 GNC will host ... at the 2008 Teva Mountain,Games Thursday through Sunday ... professionals, Kirsten and Michelle are among,the world,s top ... Games are the country,s largest,celebration of mountain sport, ...
Cached Medicine News:Health News:Cartilage regeneration '20,000 Leagues Under the Sea' 2Health News:Cartilage regeneration '20,000 Leagues Under the Sea' 3Health News:Pennsylvania DPW Secretary Corrects the Record on State Funding For Nursing Homes 2Health News:The Scientific Business of Thomson Reuters Publishes Pharma Matters - a Series of Reviews Covering Various Aspects of the Pharmaceutical Pipeline 2Health News:The Scientific Business of Thomson Reuters Publishes Pharma Matters - a Series of Reviews Covering Various Aspects of the Pharmaceutical Pipeline 3Health News:Cardiologists Warn Proposed Changes Would Close Outpatient Cardiac Cath Labs 2Health News:Cardiologists Warn Proposed Changes Would Close Outpatient Cardiac Cath Labs 3Health News:Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vail's Teva Mountain Games 2
(Date:3/6/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rvhg65/european_patient ... Patient Handling Equipment Market by Product, by Type of ... 2019" report to their offering. ... grow at a double-digit CAGR of 11.4% to reach ... as rising geriatric population, increasing incidences of lifestyle diseases, ...
(Date:3/6/2015)... , March 6, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... earned a $9 million milestone payment from Biogen Idec ... evaluating ISIS-SMN Rx in infants with spinal muscular ... study of ISIS-SMN Rx, is a randomized, double-blind, ... diagnosed with SMA.  The study will evaluate the efficacy ...
(Date:3/5/2015)... 2015   MeridianRx earned highest possible ... optional leading indicators during its recent URAC accreditation ... are very proud of earning this level of ... Chief Operating Officer of MeridianRx. "It is a ... transparency, flexibility and innovation." URAC,s leading ...
Breaking Medicine Technology:European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 2European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 4Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 5MeridianRx Earns Highest URAC Accreditation Status 2
... Safely And Easily Cut Foldable Silicone ... To Cut And Remove Even High ... One Instrument.,New Miniaturized Profile Allows Insertion ... Explantation Of A Silicone Lens.,Available For ...
... The Gauges Are Available As One Unit, ... To Test The Width Of A Phaco Incision. ... And Increase In Width Up To ... Use, And Provide Accurate Information As To The ...
... Designed To Rest Either Nasally Or ... Over, Allowing Eyelids To Be Opened ... Widest Possible Aperture.,Open And Close With ... To The Globe During Clear Corneal ...
... To Dial An Exact Extension Of The ... Visibility, With Titanium Handle & Spring. ,Unique ... Tissue, And Can Also Be Dialed To ... Made In The USA, Handle Guaranteed For ...
Medicine Products: